Podcast

Breast Cancer Update

Author: Dr. Neil Love
Feed episode count: 118
Official site: https://www.researchtopractice.com/browse-by-tumor-types/breast-cancer
RSS: https://feeds.captivate.fm/breast-oncology/
JSON: /v1/public/podcasts/breast-cancer-update-757579
Markdown: /podcast/breast-cancer-update-757579.md

Summary

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.

Episodes

Sep 21, 2026 · not_requested

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 1 with Dr David W Cescon

Duration seconds: 1784
Source: https://breast-oncology.captivate.fm/episode/6144-5mjc2026-tnbc-1

HTML Markdown JSON

Sep 15, 2026 · not_requested

Breast Cancer — Reviewing Key Presentations from the 2026 ASCO Annual Meeting

Duration seconds: 5376
Source: https://breast-oncology.captivate.fm/episode/6177-postasco2026-breast

HTML Markdown JSON

Sep 3, 2026 · not_requested

ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists

Duration seconds: 3483
Source: https://breast-oncology.captivate.fm/episode/5932-firstlinetherapyher2mbc26-2

HTML Markdown JSON

Aug 28, 2026 · not_requested

Metastatic Triple-Negative Breast Cancer — Patterns of Care

Duration seconds: 3743
Source: https://breast-oncology.captivate.fm/episode/6120-mtnbc26-2

HTML Markdown JSON

Aug 24, 2026 · not_requested

HR-Positive Metastatic Breast Cancer — Year in Review Series on Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway

Duration seconds: 3534
Source: https://breast-oncology.captivate.fm/episode/6110-yir2025-pi3k-akt-mtor-bc

HTML Markdown JSON

Aug 18, 2026 · not_requested

For Oncology Nurses: Oral Selective Estrogen Receptor Degraders in Breast Cancer — Proceedings from the 2026 Annual ONS Congress

Duration seconds: 5087
Source: https://breast-oncology.captivate.fm/episode/6100-ons2026-oralserdsbreast

HTML Markdown JSON

Aug 10, 2026 · not_requested

For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress

Duration seconds: 5396
Source: https://breast-oncology.captivate.fm/episode/6020-ons2026-pi3k-akt-mtor-mbc

HTML Markdown JSON

Jul 29, 2026 · not_requested

For Oncology Nurses: CDK4/6 Inhibitors for Breast Cancer — Proceedings from the 2026 Annual ONS Congress

Duration seconds: 5348
Source: https://breast-oncology.captivate.fm/episode/6097-ons2026-cdk46bc

HTML Markdown JSON

Jul 25, 2026 · not_requested

Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway

Duration seconds: 7096
Source: https://breast-oncology.captivate.fm/episode/6082-asco2026-serds-pi3k-akt-mtor-bc

HTML Markdown JSON

Jul 18, 2026 · not_requested

HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy

Duration seconds: 2788
Source: https://breast-oncology.captivate.fm/episode/6091-oncologytodayfirstlineher2posmbc26

HTML Markdown JSON

Jul 13, 2026 · not_requested

Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Duration seconds: 3492
Source: https://breast-oncology.captivate.fm/episode/6044-yir2025-localizedhrposbc

HTML Markdown JSON

Jul 10, 2026 · not_requested

For Oncology Nurses: Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress

Duration seconds: 5334
Source: https://breast-oncology.captivate.fm/episode/5899-ons2026-adc

HTML Markdown JSON

Jul 8, 2026 · not_requested

Antibody-Drug Conjugates in the Management of Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Duration seconds: 7200
Source: https://breast-oncology.captivate.fm/episode/6064-asco2026-adcbreast

HTML Markdown JSON

Jun 29, 2026 · not_requested

HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

Duration seconds: 5959
Source: https://breast-oncology.captivate.fm/episode/6009-gmo26-hrposbc

HTML Markdown JSON

Jun 26, 2026 · not_requested

Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know

Duration seconds: 3223
Source: https://breast-oncology.captivate.fm/episode/6116-mtnbc26-1

HTML Markdown JSON

Jun 23, 2026 · not_requested

HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

Duration seconds: 3137
Source: https://breast-oncology.captivate.fm/episode/6009-gmo26-her2posbc

HTML Markdown JSON

Jun 22, 2026 · not_requested

Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper

Duration seconds: 1426
Source: https://breast-oncology.captivate.fm/episode/5790-ppdesmoid2025-4

HTML Markdown JSON

Jun 20, 2026 · not_requested

Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit

Duration seconds: 2959
Source: https://breast-oncology.captivate.fm/episode/6009-gmo26-tnbc

HTML Markdown JSON

Jun 11, 2026 · not_requested

HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy

Duration seconds: 3502
Source: https://breast-oncology.captivate.fm/episode/5904-cochrposmbc2025

HTML Markdown JSON

Jun 2, 2026 · not_requested

Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper

Duration seconds: 1370
Source: https://breast-oncology.captivate.fm/episode/5788-ppdesmoid2025-3

HTML Markdown JSON

Apr 30, 2026 · not_requested

Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Duration seconds: 3438
Source: https://breast-oncology.captivate.fm/episode/5924-yir2025-oralserdsbreast

HTML Markdown JSON

Apr 16, 2026 · not_requested

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

Duration seconds: 3613
Source: https://breast-oncology.captivate.fm/episode/5693-oncologytodaybiomarkershrposmbc25

HTML Markdown JSON

Apr 14, 2026 · not_requested

ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy

Duration seconds: 3479
Source: https://breast-oncology.captivate.fm/episode/5928-firstlinetherapyher2mbc26-1

HTML Markdown JSON

Apr 7, 2026 · not_requested

Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan

Duration seconds: 1694
Source: https://breast-oncology.captivate.fm/episode/5785-ppdesmoid2025-2

HTML Markdown JSON

Mar 30, 2026 · not_requested

Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway

Duration seconds: 4532
Source: https://breast-oncology.captivate.fm/episode/5847-diabetologyerposmbc2026

HTML Markdown JSON

Mar 18, 2026 · not_requested

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Duration seconds: 1821
Source: https://breast-oncology.captivate.fm/episode/5737-5mjc2025-ctdnaassays-breast

HTML Markdown JSON

Mar 16, 2026 · not_requested

Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan

Duration seconds: 1003
Source: https://breast-oncology.captivate.fm/episode/5783-ppdesmoid2025-1

HTML Markdown JSON

Mar 2, 2026 · not_requested

Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Duration seconds: 3520
Source: https://breast-oncology.captivate.fm/episode/5915-yir2025-adcbreast

HTML Markdown JSON

Jan 27, 2026 · not_requested

Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Duration seconds: 7267
Source: https://breast-oncology.captivate.fm/episode/5642-sanantoniohrposbc25

HTML Markdown JSON

Jan 14, 2026 · not_requested

HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Duration seconds: 7098
Source: https://breast-oncology.captivate.fm/episode/5623-sanantonioher2posbc25

HTML Markdown JSON

Jan 8, 2026 · not_requested

Antibody-Drug Conjugates for Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Duration seconds: 5421
Source: https://breast-oncology.captivate.fm/episode/5647-sanantonioadcsmbc25

HTML Markdown JSON

Dec 23, 2025 · not_requested

Toxicities Associated with Antibody-Drug Conjugates for Metastatic Breast Cancer — Clinical Investigator Perspectives on Actual Patient Cases

Duration seconds: 3614
Source: https://breast-oncology.captivate.fm/episode/5583-pp2025-adctoxmbc

HTML Markdown JSON

Dec 8, 2025 · not_requested

Breast Cancer — Highlights from the 2025 ESMO Annual Meeting

Duration seconds: 5259
Source: https://breast-oncology.captivate.fm/episode/5629-postesmobreast25

HTML Markdown JSON

Dec 5, 2025 · not_requested

Breast Cancer — Microlearning Activity Issue 3 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Duration seconds: 927
Source: https://breast-oncology.captivate.fm/episode/5635-postesmobreast25-micro-3

HTML Markdown JSON

Dec 2, 2025 · not_requested

Breast Cancer — Microlearning Activity 2 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Duration seconds: 1015
Source: https://breast-oncology.captivate.fm/episode/5633-postesmobreast25-micro-2

HTML Markdown JSON

Nov 29, 2025 · not_requested

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 2

Duration seconds: 3534
Source: https://breast-oncology.captivate.fm/episode/5506-oralserdsmbc2025-2

HTML Markdown JSON

Nov 26, 2025 · not_requested

Breast Cancer — Microlearning Activity 1 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Duration seconds: 769
Source: https://breast-oncology.captivate.fm/episode/5631-postesmobreast25-micro-1

HTML Markdown JSON

Nov 20, 2025 · not_requested

HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders

Duration seconds: 3516
Source: https://breast-oncology.captivate.fm/episode/5625-hrposmbcprotac25

HTML Markdown JSON

Nov 14, 2025 · not_requested

ER-Positive Metastatic Breast Cancer — A Roundtable Discussion on the Current and Future Role of Oral SERDs

Duration seconds: 9036
Source: https://breast-oncology.captivate.fm/episode/5585-oralserdsmbcthinktank2025

HTML Markdown JSON

Nov 10, 2025 · not_requested

Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Duration seconds: 7071
Source: https://breast-oncology.captivate.fm/episode/5673-fcs2025-breast

HTML Markdown JSON

Nov 5, 2025 · not_requested

ER-Positive Metastatic Breast Cancer — An Interview with Prof Patrick Neven on the Role of Oral Selective Estrogen Receptor Degraders

Duration seconds: 2477
Source: https://breast-oncology.captivate.fm/episode/5690-oncologytoday25-oralserdserposmbc

HTML Markdown JSON

Oct 27, 2025 · not_requested

Breast Cancer — 5-Minute Journal Club Issue 4 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Duration seconds: 940
Source: https://breast-oncology.captivate.fm/episode/5461-5mjc2025-trop2breast-4

HTML Markdown JSON

Oct 21, 2025 · not_requested

Metastatic Breast Cancer — Current and Future Integration of Antibody-Drug Conjugates

Duration seconds: 3406
Source: https://breast-oncology.captivate.fm/episode/5580-pp2025-adcsmbc

HTML Markdown JSON